Histone H2B human recombinant 03-185
LSD1 human recombinant 03-229
PCAF human recombinant 03-187
SET7/9 human recombinant 03-209
Small Molecules and inhibitors
CARM1 Inhibitor 217531-10MG
Releasing Factor C5348 1392 CRH P NP_000747.1 y y y
188 Crk II C0853 1398 CRK P NP_005197.3 y y n/d
187 Crk-L C0978 1399 CRKL P NP_005198.1 y y n/d
534 p38 MAP Kinase, Non-Activated M8432 1432 MAPK14 M NP
Releasing Factor C5348 1392 CRH P NP_000747.1 y y y
188 Crk II C0853 1398 CRK P NP_005197.3 y y n/d
187 Crk-L C0978 1399 CRKL P NP_005198.1 y y n/d
534 p38 MAP Kinase, Non-Activated M8432 1432 MAPK14 M NP
Releasing Factor C5348 1392 CRH P NP_000747.1 y y y
188 Crk II C0853 1398 CRK P NP_005197.3 y y n/d
187 Crk-L C0978 1399 CRKL P NP_005198.1 y y n/d
534 p38 MAP Kinase, Non-Activated M8432 1432 MAPK14 M NP
NE1013 Undiluted serum. Immunogen used was a synthetic peptide coresponding
to amino acid residues 187-202 of PGP9.5. Detects the ~26 kDa PGP9.5, a
ubiquitin hydrolase widely expressed in neuronal tissues
blocks (PEO−PPO−PEO). Pluronic F127 has been approved
by FDA as a human-use cytocompatible biomaterial.187 It
shows polymer concentration-dependent thermoreversible sol−
gel transition. Above a critical micelle
Cortactin C6987 P y y y
185 Corticotropin Releasing Factor C5348 P y y y
186 COX II C9354 M y n/d n/d
187 Crk-L C0978 P y y n/d
188 Crk II C0853 P y y n/d
189 Csk C7863 P y n/d y
190
blocks (PEO−PPO−PEO). Pluronic F127 has been approved
by FDA as a human-use cytocompatible biomaterial.187 It
shows polymer concentration-dependent thermoreversible sol−
gel transition. Above a critical micelle
CRH NP_000747.1,NP_991338.1,NP_112281.1 P y y y
186 COX II C9354 5743 PTGS2 NP_000954.1 M y n/d n/d
187 Crk-L C0978 1399, 12929 CRKL,Crkl NP_005198.1,NP_031790.2 P y y n/d
188 Crk II C0853 12928, 1398 Crk
CRH NP_000747.1,NP_991338.1,NP_112281.1 P y y y
186 COX II C9354 5743 PTGS2 NP_000954.1 M y n/d n/d
187 Crk-L C0978 1399, 12929 CRKL,Crkl NP_005198.1,NP_031790.2 P y y n/d
188 Crk II C0853 12928, 1398 Crk
cDNA (activated) in pUSEamp TFX 5 µg 21-189
RalA cDNA (dominant negative) in pUSEamp TFX 5 µg 21-187
RalA cDNA (wt) in pUSEamp TFX 5 µg 21-190
Ran
Antibody
Ran H Xn WB IP IC antiserum Rb
186 User Guide
Priming the System
Mobius® Chrom 20 System with Flexware® Assemblies 187
188 User Guide
Introduction
Once the Flexware® Assemblies are installed and